Archive for: July 2008

HealthDay - TUESDAY, July 29 (HealthDay News) -- Men undergoing hormone deprivation therapy to keep prostate cancer at bay may experience memory loss and have trouble concentrating, a new study finds.

American Cancer Society - Promising--yet preliminary--results from an early clinical trial show that the experimental drug abiraterone can significantly reduce the size of prostate cancer tumors in men who haven't responded to other therapies.

Reuters - Nearly one-third of leukemia patients do not respond to chemotherapy, but this is not typically discovered until they have already endured a week-long course of chemotherapy and waited even longer to see if the chemotherapy worked.

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

HealthDay - Here are some of the latest health and medical news developments, compiled by editors of HealthDay:

HealthDay - MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that's almost always caused by exposure to asbestos.

Reuters - A once-a-day pill significantly shrank tumors in men with advanced prostate cancer who had not responded to other treatments, researchers said on Tuesday.

Reuters - Black men with early prostate cancer may be less likely to receive aggressive treatment than their white counterparts, a small study has found.

HealthDay - WEDNESDAY, July 16 (HealthDay News) -- Your odds of surviving cancer depend on which country you live in. And, in the United States, it also depends on whether you're black or white, a new study finds.

HealthDay - TUESDAY, July 15 (HealthDay News) -- A new imaging technique, based on an engineered version of the common cold virus, may help doctors detect the spread of prostate cancer to the lymph nodes earlier.